Literature DB >> 8824531

Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.

G Bellec1, Y Dréano, P Lozach, J F Ménez, F Berthou.   

Abstract

The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitrosodiethylamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitrosodialkylamines (nitrosomethylethylamine, nitrosomethylpropylamine, nitrosomethylbutylamine and nitrosomethylamylamine), was investigated in 14 samples of human liver microsomes. All these nitrosodialkylamines were dealkytated to aldehydes that were separated by reversed phase HPLC and UV detected as dinitrophenylhydrazones. As the length of the alkyl chain increased from methyl to pentyl, dealkylation of symmetrical nitrosodialkylamines became less efficiently catalyzed by cytochrome P450. Conversely, oxidation of the methyl moiety of asymmetrical nitrosomethylalkylamines increased with the size of the alkyl moiety, while dealkylation of the longer alkyl group decreased. N-Dealkylase activities were significantly correlated with P450 activities measured in human liver microsomes. These catalytic activities involve CYP2A6 (coumarin 7-hydroxylation), CYP2C (mephenytoin 4-hydroxylation and tolbutamide hydroxylation), CYP2D6 (dextromethorphan O-demethylation), CYP2E1 (chlorzoxazone and p-nitrophenol hydroxylation) and CYP3A4 (nifedipine oxidation). By using 10 heterologously expressed P450s, it was shown that nitrosodimethylamine was mainly demethylated by CYP2E1. However, such enzyme specificity was lost with increasing size of the alkyl group. Therefore, the chain length of the alkyl group of nitrosodialkylamines determined the P450 involved in its oxidation. All these results emphasize that the catalytic site of P450 2EI has a geometric configuration such that only small molecules like nitrosodimethylamine fit favorably within the putative active site of the enzyme. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, 2C8/2C9/2C19 and 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824531     DOI: 10.1093/carcin/17.9.2029

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.

Authors:  Dong Lu; Xiaodan Yu; Yukai Du
Journal:  Mol Biol Rep       Date:  2010-11-13       Impact factor: 2.316

3.  Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China.

Authors:  Xiao-Mei Lu; Yue-Ming Zhang; Ren-Yong Lin; Gul Arzi; Xing Wang; Ya-Lou Zhang; Yan Zhang; Yan Wang; Hao Wen
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

4.  CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: a meta-analysis.

Authors:  Keqing Yao; Haiping Qin; Lili Gong; Ran Zhang; Lianqing Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

5.  Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Liang Song; Ling Peng; Zhibin Bu; Sen-Xiang Yan; Jie Feng; Xin-Li Zhu; Xin-Biao Liao; Xue-Lin Yu; Danfang Yan
Journal:  Mol Genet Genomics       Date:  2014-10-22       Impact factor: 3.291

6.  Computationally Assessing the Bioactivation of Drugs by N-Dealkylation.

Authors:  Na Le Dang; Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  Chem Res Toxicol       Date:  2018-02-06       Impact factor: 3.739

7.  Developing Structure-Activity Relationships for N-Nitrosamine Activity.

Authors:  Kevin P Cross; David J Ponting
Journal:  Comput Toxicol       Date:  2021-09-08

8.  Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies.

Authors:  Ming-Xing Zhang; Kai Liu; Fu-Gang Wang; Xiao-Wen Wen; Xi-Lin Song
Journal:  Mol Clin Oncol       Date:  2016-03-18

9.  CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.

Authors:  Wenlei Zhuo; Liang Zhang; Yan Wang; Junjun Ling; Bo Zhu; Zhengtang Chen
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

10.  Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.

Authors:  Jin Feng; Xiaolin Pan; Junbo Yu; Zheng Chen; Hao Xu; Wael El-Rifai; Guoxin Zhang; Zekuan Xu
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.